Susquehanna International Group
TTNP

Susquehanna International Group’s Titan Pharmaceuticals TTNP Stock Holding History

Susquehanna International Group’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-545
Closed -$9.05K – 13161
2023
Q1 		$9.05K Sell
545
-580
-52% -$10.4K ﹤0.01% 12223
2022
Q4 		$17.6K Sell
1,125
-745
-40% -$14.1K ﹤0.01% 11805
2022
Q3 		$40K Buy
1,870
+1,320
+240% +$34.1K ﹤0.01% 12335
2022
Q2 		$6K Sell
550
-130
-19% -$1.62K ﹤0.01% 12592
2022
Q1 		$13K Sell
680
-3,035
-82% -$63.1K ﹤0.01% 12719
2021
Q4 		$76K Buy
+3,715
New +$112K ﹤0.01% 12317
2021
Q3 		– Sell
-3,745
Closed -$195K – 13593
2021
Q2 		$195K Sell
3,745
-6,350
-63% -$318K ﹤0.01% 11629
2021
Q1 		$602K Buy
10,095
+7,130
+240% +$472K ﹤0.01% 9051
2020
Q4 		$195K Buy
2,965
+2,864
+2,836% +$226K ﹤0.01% 10070
2020
Q3 		$10K Sell
101
-77
-43% -$11.9K ﹤0.01% 10418
2020
Q2 		$33K Sell
178
-286
-62% -$49.2K ﹤0.01% 9850
2020
Q1 		$65K Buy
464
+447
+2,629% +$69.8K ﹤0.01% 9556
2019
Q4 		$2K Sell
17
-14
-45% -$1.69K ﹤0.01% 9589
2019
Q3 		$5K Sell
31
-236
-88% -$106K ﹤0.01% 10049
2019
Q2 		$205K Buy
267
+120
+82% +$110K ﹤0.01% 9085
2019
Q1 		$157K Buy
147
+142
+2,840% +$138K ﹤0.01% 8014
2018
Q4 		$4K Buy
+5
New +$5.61K ﹤0.01% 8795
2017
Q3 		– Sell
-6
Closed -$38K – 9649
2017
Q2 		$38K Sell
6
-13
-68% -$121K ﹤0.01% 8943
2017
Q1 		$224K Hold
19
– – ﹤0.01% 7850
2016
Q4 		$270K Sell
19
-4
-17% -$67.3K ﹤0.01% 8164
2016
Q3 		$494K Sell
23
-18
-44% -$350K ﹤0.01% 6071
2016
Q2 		$812K Buy
41
+21
+105% +$447K ﹤0.01% 5258
2016
Q1 		$347K Buy
+20
New +$267K ﹤0.01% 7032

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Susquehanna International Group's TTNP Position: Q1 2024 in Review

Susquehanna International Group sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 980 shares — an estimated $8.08K sold.

Susquehanna International Group first reported a position in TTNP in Q3 2016 and held it in 13 quarters. The position peaked at $203K in Q4 2016. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.

  • Susquehanna International Group reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 980 Titan Pharmaceuticals shares in Q1 2024, an estimated $8.08K.
  • Susquehanna International Group first reported a position in Titan Pharmaceuticals in Q3 2016 and held it in 13 quarters.
  • Susquehanna International Group's Titan Pharmaceuticals position peaked at $203K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.